Results 271 to 280 of about 10,552,439 (323)
This review systematically elucidates the multifactorial anti‐aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biology with advanced bioengineering, scalable manufacturing, and clinical translation, it establishes a comprehensive framework for developing next‐generation EVs‐based precision nanotherapeutics to combat systemic ...
Xian Huang +6 more
wiley +1 more source
Serum lipids and disease progression in Huntington's disease: A retrospective cohort study. [PDF]
Zhang S +9 more
europepmc +1 more source
Mt‐dsRNA signatures increase in the human brain after midlife in parallel with disrupted mitochondrial RNA homeostasis and are further elevated in Alzheimer's disease, where they correlate with cognitive decline and neuropathology. These findings suggest that age‐related mitochondrial RNA dyshomeostasis may drive chronic inflammation and contribute to ...
Rachel L. Doser, Thomas J. LaRocca
wiley +1 more source
Dysregulation of miRNAs in Sicilian Patients with Huntington's Disease. [PDF]
Salemi M +8 more
europepmc +1 more source
Aging‐associated MLKL upregulation in hepatocytes induces mitochondrial dysfunction and oxidative stress, accompanied by increased release of pro‐inflammatory extracellular vesicles. These changes are associated with increased p16+/p21+ senescence in hepatocytes and non‐parenchymal cells (macrophages, stellate cells, and endothelial cells), suggesting ...
Sabira Mohammed +21 more
wiley +1 more source
Childhood-Onset Huntington's Disease-Like Presentation of SCA17 with Intermediate Repeats, A Case Report. [PDF]
Berns M, Jensen K, Speltz L, Almeida LB.
europepmc +1 more source
Karyopherin Dysfunction Is a Key Driver of Aging
Studies on the proteostasis network and aging have focused on protein synthesis, folding, and turnover. Here, emphasis on the spatial dimension in proteostasis is proposed by recognizing nucleocytoplasmic transport as an important player in aging. ABSTRACT Aging is often framed as the gradual erosion of proteostasis, driven by declining chaperone ...
Louis R. Lapierre
wiley +1 more source
Profiles of patients at early stages of Huntington's disease based on the routine biological markers and the disease progression. [PDF]
Gil-Salcedo A +4 more
europepmc +1 more source
Overview of Huntington's Disease and Emerging Treatment Strategies: A Narrative Review. [PDF]
Vega AJ +7 more
europepmc +1 more source
Reduced Dopamine Transporter Uptake in Dentatorubral‐Pallidoluysian Atrophy
Movement Disorders Clinical Practice, Volume 13, Issue 7, Page 1769-1771, July 2026.
Kei Okuba +3 more
wiley +1 more source

